scholarly journals Selective intra‐arterial calcium stimulation test for the localization of insulinomas: an Australian hospital experience

2020 ◽  
Vol 90 (12) ◽  
Author(s):  
Anneke Graf ◽  
Stella Sarlos ◽  
Stephen G. Farrell ◽  
Richard J. MacIsaac ◽  
Warrick J. Inder ◽  
...  
Keyword(s):  
Stimulation Test ◽  
Hospital Experience ◽  
Calcium Stimulation ◽  
Australian Hospital

Abstract #1101 The Value of Calcitonin Calcium Stimulation Test Levels as Predictors of Medullary Thyroid Cancer.

2018 ◽  
Vol 24 ◽  
pp. 273-274
Author(s):  
Corin Badiu ◽  
Mara Baet ◽  
Ruxandra Dobrescu ◽  
Andra Caragheorgheopol ◽  
Corneci Cristina
Keyword(s):  
Thyroid Cancer ◽  
Medullary Thyroid Cancer ◽  
Stimulation Test ◽  
Medullary Thyroid ◽  
Calcium Stimulation

scholarly journals Calcitonin Stimulation Tests: Rationale, Technical Issues and Side Effects: A Review

2021 ◽  
Vol 53 (06) ◽  
pp. 355-363
Author(s):  
Mara Băetu ◽  
Cristina Alexandra Olariu ◽  
Gabriel Moldoveanu ◽  
Cristina Corneci ◽  
Corin Badiu
Keyword(s):  
Side Effects ◽  
Stimulation Test ◽  
Cardiac Monitoring ◽  
Calcium Stimulation ◽  
United States Food ◽  
Stimulation Tests ◽  
Gender Specific Differences ◽  
Technical Issues ◽  
States Food ◽  
The Right

AbstractCalcitonin (CT) stimulation tests have great value and could help to: differentiate thyroid causes of elevated CT apart from non-thyroid sources, determine whether the patients with slightly elevated basal CT could/could not be candidates for surgery, and indicate the right moment for prophylactic thyroidectomy in children with MEN syndromes when with normal basal CT. This triggered the requests for development of CT stimulation tests, taking into consideration their safety and aimed us to write a systematic review of literature regarding the rationale, technical issues, and side effects of CT stimulating tests used for diagnosis of MTC. After a thorough review of the literature, we classified the reported side effects by severity, as defined by United States Food and Drug Administration. A statistical analysis was performed using IBM SPSS Statistics version 20. Various side effects were noticed during stimulation tests that differ by intensity, duration and severity, depending on types of substances and protocols used. The side effects after pentagastrin test were significantly more severe than those reported after calcium stimulation test (p=0.0396). There are also significant gender-specific differences in side effects induced by stimulation tests. In conclusion, we recommend performing Ca CT stimulation test when needed, considering preventive evaluation of some clinical, instrumental, and biochemical aspects of each patient. Precise instructions should be followed before a stimulation test and furthermore continuous cardiac monitoring is essential during and after the test to minimize the possibility of a serious event.

Postprandial Hyperinsulinemic Hypoglycaemia with Positive Selective Calcium Stimulation Test: a case of Idiopathic Reactive Hypoglycaemia.

2008 ◽  
Vol 32 (4) ◽  
pp. 354
Author(s):  
Amir Khattabi ◽  
Martin Labuda ◽  
Francis Bernard ◽  
Barbara Duda ◽  
Nicole Van Rossum ◽  
...  
Keyword(s):  
Stimulation Test ◽  
Reactive Hypoglycaemia ◽  
Calcium Stimulation ◽  
Hyperinsulinemic Hypoglycaemia

Calcium-stimulation test for the assessment of β-cell function in cats

2008 ◽  
Vol 84 (3) ◽  
pp. 364-366 ◽  
Author(s):  
L.I. Slingerland ◽  
A. Rijnberk ◽  
H.S. Kooistra
Keyword(s):  
Cell Function ◽  
Stimulation Test ◽  
Β Cell ◽  
Calcium Stimulation ◽  
Β Cell Function

The Role of Intra-Arterial Calcium Stimulation Test with Hepatic Venous Sampling (IACS) in the Management of Occult Insulinomas

2007 ◽  
Vol 14 (7) ◽  
pp. 2121-2127 ◽  
Author(s):  
Ling-Ming Tseng ◽  
Jui-Yu Chen ◽  
Justin Ging-Shing Won ◽  
Hsiao-Shan Tseng ◽  
An-Han Yang ◽  
...  
Keyword(s):  
Stimulation Test ◽  
Venous Sampling ◽  
Calcium Stimulation

scholarly journals Calcium Stimulation Test for Insulinoma Localization in an End-stage Renal Disease Patient on Diazoxide

2020 ◽  
Vol 5 (2) ◽  
Author(s):  
Stephanie Kim ◽  
Miles Conrad ◽  
Eunice Chuang ◽  
Larry Cai ◽  
Umesh Masharani ◽  
...  
Keyword(s):  
Renal Disease ◽  
End Stage Renal Disease ◽  
Esrd Patient ◽  
Disease Patient ◽  
The Body ◽  
Stimulation Test ◽  
Delay In Diagnosis ◽  
Calcium Stimulation ◽  
Stage Renal Disease ◽  
End Stage

Abstract Insulinomas are rare, and even rarer in patients with end-stage renal disease (ESRD). Clear criteria for the biochemical diagnosis of insulinomas in patients with renal failure have not been established, and hypoglycemia is often attributed to the renal disease itself, frequently leading to a delay in diagnosis. We describe a case of a patient who presented with asymptomatic recurrent hypoglycemia during hemodialysis. Disease progression and biochemical testing strongly suggested an insulinoma. Computed tomography (CT) of the abdomen and pelvis, 111In-pentetreotide scintigraphy and endoscopic ultrasound did not localize a pancreatic tumor. A calcium stimulation test was performed while the patient was taking diazoxide due to severe hypoglycemia with fasting for a couple of hours without treatment. The test showed a marked increase in insulin after calcium infusion in the dorsal pancreatic artery, localizing the tumor to the body and tail of the gland. Exploratory surgery easily identified a tumor at the body of the pancreas and pathology confirmed an insulin-secreting pancreatic neuroendocrine tumor. On follow-up, there was resolution of the hypoglycemia. We review the challenges of diagnosing an insulinoma in ESRD and describe a successful intra-arterial calcium stimulation test done in an ESRD patient while continuing diazoxide.

scholarly journals A Case Report of Insulinoma Located with Calcium Stimulation Test

2014 ◽  
Vol 52 (4) ◽  
pp. 296-298
Author(s):  
Mazhar Müslüm Tuna ◽  
Berçem Ayçiçek Doğan ◽  
Ayşe Arduç ◽  
Gülhan Akbaba ◽  
Kerim Küçükler ◽  
...  
Keyword(s):  
Case Report ◽  
Stimulation Test ◽  
Calcium Stimulation

scholarly journals Patients with papillary thyroid carcinoma associated with high stimulated serum calcitonin levels

2017 ◽  
Vol 2017 ◽  
Author(s):  
Kursad Unluhizarci ◽  
Hulya Akgun ◽  
Bahadır Oz ◽  
Zuleyha Karaca ◽  
Fatih Tanriverdi ◽  
...  
Keyword(s):  
Papillary Thyroid Carcinoma ◽  
Thyroid Carcinoma ◽  
Thyroid Nodules ◽  
Stimulation Test ◽  
List Type ◽  
Papillary Thyroid ◽  
Serum Calcitonin ◽  
Calcium Stimulation ◽  
Ct Measurement

Summary Among various substances produced by C-cells, the most important one is calcitonin (CT) that is used for detection, post-operative follow-up and evaluation of individuals at risk of developing medullary thyroid carcinoma (MTC). However, the role of serum CT measurement in the evaluation of thyroid nodules has been widely discussed, and there is still no consensus about the role of CT in the initial evaluation of all thyroid nodules. Two patients with thyroid nodules whose fine-needle aspiration results were compatible with benign cytology besides having mildly elevated basal serum calcitonin levels were reported. Calcitonin responses (peak levels were 313 and 229 pg/mL, respectively) to calcium stimulation test were compatible with the possible diagnosis of MTC. However, the final diagnosis was papillary thyroid carcinoma of the thyroid gland. There are limited numbers of case reports showing such an increased serum calcitonin responses to calcium stimulation test associated with papillary or follicular thyroid carcinoma of the thyroid. We suggest to measure serum CT level once and in case of normal levels, no further CT measurement is necessary. Physicians should keep in mind that thyroid carcinomas other than MTCs may also be associated with high serum CT levels. Learning points: Although serum calcitonin is a valuable tumor marker for MTC, it is well known that mild elevations may be seen in some other diseases such as Hashimoto thyroiditis, neuroendocrine tumors or due to medications such as proton pump inhibitors, calcium salts, beta blockers and glucocorticoids. Those two cases indicate that high calcitonin responses to calcium stimulation test, mimicking MTC, may also be seen in patients with papillary thyroid carcinoma although the mechanism is not clear.

Sign in / Sign up

Export Citation Format

Share Document